Novo Nordisk shares jumped 8% Monday after Hims & Hers said it will pull its copycat weight-loss pill off the market.

Hims & Hers (HIMS) stock falls as Novo Nordisk (NVO) sues the firm over a key patent related to its weight loss therapy ...

Senior Advocate Murari Tiwari, former Chairman of the Bar Council of Delhi, highlighted the importance of legal awareness and constructive dialogue, noting that platforms like Trust Talk can help ...

The pharma giant alleges that Hims & Hers is infringing its patents and misleading consumers by selling unsafe, unapproved ...

Citizens JMP issued a new note that moved its view on SoFi Technologies to outperform from market perform. The change ...

Novo Nordisk has sued Hims for allegedly violating patents protecting semaglutide, seeking potentially “hundreds of millions” in damages, John Kuckelman, the pharma’s general counsel, said. The ...

Airbnb’s implied fair value per share is now set at US$143.75, only a fraction above the prior US$143.23, which fits with how tightly recent Street price targets are clustering around the current ...

We recently published an article titled 13 High Growth Cloud Stocks to Buy. Datadog, Inc. (NASDAQ:DDOG) is among the ...

By Inti Landauro and Sudip Kar-Gupta PARIS, Feb 3 (Reuters) - French police raided the offices of Elon Musk's social media ...

As Novo Nordisk surges and Hims & Hers tanks, analysts see relief for Novo from competition in the compounded pill segment ...

Q3 2026 Management View Scott Hart, CEO, began by stating that "we generated strong results to cap off a very successful calendar year in 2025" and that the quarter marked their "best quarter ever in ...